| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.562 | 0.013 | 0.562 | GABA C receptor rho-3 antagonist | 0.378 0.071 CID_36332 | ||
| 0.537 | 0.022 | 0.537 | 5 Hydroxytryptamine release stimulant | 0.216 0.109 CID_36332 | ||
| 0.517 | 0.03 | 0.517 | Aldehyde oxidase inhibitor | 0.183 0.114 CID_36332 | ||
| 0.484 | 0.011 | 0.484 | Peroxidase inhibitor | 0.203 0.058 CID_36332 | ||
| 0.48 | 0.015 | 0.48 | Superoxide dismutase inhibitor | 0.248 0.076 CID_36332 | ||
| 0.466 | 0.043 | 0.466 | Calcium channel L-type activator | 0.4 0.081 CID_36332 | ||
| 0.449 | 0.062 | 0.449 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.443 0.066 CID_36332 | ||
| 0.398 | 0.017 | 0.398 | Anesthetic general | 0.371 0.02 CID_36332 | ||
| 0.424 | 0.064 | 0.519 | 5 Hydroxytryptamine release inhibitor | 0.519 0.027 CID_36332 | CID_36332 | |
| 0.422 | 0.064 | 0.496 | Histamine release inhibitor | 0.496 0.03 CID_36332 | CID_36332 | |
| 0.374 | 0.019 | 0.374 | 5 Hydroxytryptamine uptake stimulant | 0.278 0.058 CID_36332 | ||
| 0.338 | 0.004 | 0.338 | GABA C receptor rho-2 antagonist | 0.219 0.02 CID_36332 | ||
| 0.351 | 0.024 | 0.351 | RNA-directed DNA polymerase inhibitor | 0.236 0.059 CID_36332 | ||
| 0.424 | 0.097 | 0.488 | Caspase 9 stimulant | 0.488 0.064 CID_36332 | CID_36332 | |
| 0.329 | 0.004 | 0.329 | GABA C receptor antagonist | 0.175 0.019 CID_36332 | ||
| 0.334 | 0.01 | 0.334 | Anesthetic local | 0.264 0.017 CID_36332 | ||
| 0.342 | 0.018 | 0.342 | Tyrosine 3 hydroxylase inhibitor | 0.281 0.044 CID_36332 | ||
| 0.317 | 0.006 | 0.317 | Ferrochelatase inhibitor | 0.312 0.006 CID_36332 | ||
| 0.348 | 0.047 | 0.404 | Interleukin 2 agonist | 0.404 0.026 CID_36332 | CID_36332 | |
| 0.311 | 0.015 | 0.311 | Neurotrophic factor enhancer | 0.241 0.044 CID_36332 | ||
| 0.295 | 0.004 | 0.295 | GABA C receptor rho-1 antagonist | 0.184 0.011 CID_36332 | ||
| 0.305 | 0.02 | 0.305 | Lipocortins synthesis antagonist | 0.136 0.128 CID_36332 | ||
| 0.34 | 0.057 | 0.34 | Calcium channel activator | 0.226 0.177 CID_36332 | ||
| 0.286 | 0.01 | 0.286 | GABA C receptor agonist | 0.142 0.037 CID_36332 | ||
| 0.288 | 0.015 | 0.288 | Nitric-oxide synthase stimulant | 0.24 0.04 CID_36332 | ||
| 0.28 | 0.013 | 0.28 | MAP kinase kinase 3 inhibitor | |||
| 0.311 | 0.043 | 0.4 | Interleukin agonist | 0.4 0.019 CID_36332 | CID_36332 | |
| 0.263 | 0.005 | 0.263 | NMDA 2 receptor antagonist | 0.161 0.014 CID_36332 | ||
| 0.349 | 0.1 | 0.349 | 15-Lipoxygenase inhibitor | 0.286 0.14 CID_36332 | ||
| 0.268 | 0.022 | 0.268 | Phospholipase C inhibitor | 0.19 0.051 CID_36332 | ||
| 0.29 | 0.046 | 0.29 | Cyclic AMP phosphodiesterase inhibitor | 0.248 0.064 CID_36332 | ||
| 0.287 | 0.043 | 0.287 | Gastrin inhibitor | 0.278 0.05 CID_36332 | ||
| 0.246 | 0.004 | 0.246 | NMDA 2A receptor antagonist | 0.115 0.01 CID_36332 | ||
| 0.26 | 0.021 | 0.496 | Alpha-N-acetylglucosaminidase inhibitor | 0.496 0.005 CID_36332 | CID_36332 | |
| 0.236 | 0.005 | 0.236 | Nitric-oxide synthase inhibitor | 0.11 0.046 CID_36332 | ||
| 0.234 | 0.005 | 0.234 | NMDA 2C receptor antagonist | 0.14 0.008 CID_36332 | ||
| 0.313 | 0.083 | 0.313 | Cholesterol antagonist | 0.199 0.165 CID_36332 | ||
| 0.228 | 0.008 | 0.228 | Photosensitizer | 0.144 0.034 CID_36332 | ||
| 0.226 | 0.008 | 0.226 | HIV-1 reverse transcriptase inhibitor | 0.094 0.034 CID_36332 | ||
| 0.227 | 0.013 | 0.227 | MAP kinase 8 inhibitor | |||
| 0.283 | 0.07 | 0.308 | Insulysin inhibitor | 0.308 0.054 CID_36332 | CID_36332 | |
| 0.268 | 0.056 | 0.282 | 5 Hydroxytryptamine 1E antagonist | 0.282 0.043 CID_36332 | CID_36332 | |
| 0.263 | 0.052 | 0.263 | Anticonvulsant | |||
| 0.234 | 0.025 | 0.279 | 5 Hydroxytryptamine 3E antagonist | 0.279 0.007 CID_36332 | CID_36332 | |
| 0.23 | 0.025 | 0.23 | Cyclooxygenase 1 inhibitor | 0.111 0.089 CID_36332 | ||
| 0.262 | 0.059 | 0.262 | DNA synthesis inhibitor | 0.187 0.144 CID_36332 | ||
| 0.219 | 0.018 | 0.219 | Arachidonic acid antagonist | 0.181 0.053 CID_36332 | ||
| 0.208 | 0.01 | 0.208 | HIV-1 integrase (Overall Integration) inhibitor | 0.106 0.049 CID_36332 | ||
| 0.212 | 0.015 | 0.279 | Cyclooxygenase 3 inhibitor | 0.279 0.007 CID_36332 | CID_36332 | |
| 0.23 | 0.034 | 0.23 | Heat shock protein 90 alpha antagonist | 0.181 0.062 CID_36332 | ||
| 0.214 | 0.02 | 0.214 | MAP kinase 9 inhibitor | |||
| 0.201 | 0.008 | 0.201 | Inducible nitric-oxide synthase inhibitor | 0.082 0.058 CID_36332 | ||
| 0.248 | 0.059 | 0.278 | Neuropeptide Y2 antagonist | 0.278 0.032 CID_36332 | CID_36332 | |
| 0.221 | 0.035 | 0.221 | Succinate dehydrogenase inhibitor | 0.198 0.051 CID_36332 | ||
| 0.3 | 0.114 | 0.445 | Calpain 2 inhibitor | 0.445 0.04 CID_36332 | CID_36332 | |
| 0.217 | 0.032 | 0.217 | Interleukin 6 antagonist | |||
| 0.233 | 0.05 | 0.233 | Non-steroidal antiinflammatory agent | 0.206 0.066 CID_36332 | ||
| 0.197 | 0.015 | 0.197 | NMDA receptor antagonist | 0.132 0.03 CID_36332 | ||
| 0.197 | 0.016 | 0.197 | 5 Hydroxytryptamine 3A agonist | 0.108 0.067 CID_36332 | ||
| 0.24 | 0.062 | 0.24 | Psychostimulant | 0.145 0.12 CID_36332 | ||
| 0.192 | 0.015 | 0.192 | DNA directed RNA polymerase inhibitor | |||
| 0.21 | 0.033 | 0.21 | Heat shock protein 90 antagonist | 0.146 0.078 CID_36332 | ||
| 0.228 | 0.054 | 0.228 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.207 0.066 CID_36332 | ||
| 0.178 | 0.005 | 0.178 | GABA aminotransferase inhibitor | 0.105 0.023 CID_36332 | ||
| 0.187 | 0.016 | 0.187 | Interleukin 8 antagonist | 0.146 0.036 CID_36332 | ||
| 0.249 | 0.079 | 0.249 | Aryl hydrocarbon receptor agonist | 0.237 0.084 CID_36332 | ||
| 0.277 | 0.107 | 0.277 | Vasodilator, coronary | |||
| 0.204 | 0.034 | 0.21 | ATPase inhibitor | 0.21 0.029 CID_36332 | CID_36332 | |
| 0.18 | 0.014 | 0.243 | Sphingosine 1-phosphate receptor 4 antagonist | 0.243 0.005 CID_36332 | CID_36332 | |
| 0.186 | 0.021 | 0.186 | Carbonic anhydrase XV inhibitor | 0.133 0.038 CID_36332 | ||
| 0.197 | 0.036 | 0.197 | Neurotensin receptor agonist | 0.176 0.054 CID_36332 | ||
| 0.197 | 0.037 | 0.268 | Hexokinase inhibitor | 0.268 0.014 CID_36332 | CID_36332 | |
| 0.204 | 0.049 | 0.272 | 3C-like protease (Human coronavirus) inhibitor | 0.272 0.019 CID_36332 | CID_36332 | |
| 0.171 | 0.02 | 0.171 | Adenylate kinase inhibitor | 0.101 0.066 CID_36332 | ||
| 0.172 | 0.021 | 0.172 | Antineoplastic alkaloid | 0.122 0.037 CID_36332 | ||
| 0.165 | 0.017 | 0.165 | Porphobilinogen synthase inhibitor | 0.103 0.034 CID_36332 | ||
| 0.177 | 0.03 | 0.177 | Cathepsin H inhibitor | 0.15 0.046 CID_36332 | ||
| 0.185 | 0.039 | 0.185 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.18 | 0.036 | 0.18 | CF transmembrane conductance regulator agonist | 0.173 0.043 CID_36332 | ||
| 0.242 | 0.099 | 0.242 | Immunostimulant | 0.223 0.108 CID_36332 | ||
| 0.192 | 0.05 | 0.192 | Polo-like kinase-3 inhibitor | |||
| 0.155 | 0.013 | 0.155 | Toll-Like receptor 3 antagonist | 0.097 0.056 CID_36332 | ||
| 0.17 | 0.028 | 0.17 | Beta amyloid protein antagonist | |||
| 0.258 | 0.121 | 0.282 | Vasodilator, peripheral | 0.282 0.106 CID_36332 | CID_36332 | |
| 0.16 | 0.024 | 0.16 | Ca2+-transporting ATPase inhibitor | 0.139 0.079 CID_36332 | ||
| 0.199 | 0.063 | 0.199 | LIM domain kinase 1 inhibitor | 0.143 0.105 CID_36332 | ||
| 0.223 | 0.088 | 0.302 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.302 0.064 CID_36332 | CID_36332 | |
| 0.168 | 0.035 | 0.168 | Adenylate cyclase inhibitor | 0.105 0.08 CID_36332 | ||
| 0.156 | 0.024 | 0.156 | Gastric antisecretory | 0.119 0.043 CID_36332 | ||
| 0.244 | 0.112 | 0.264 | 12-Lipoxygenase inhibitor | 0.264 0.101 CID_36332 | CID_36332 | |
| 0.255 | 0.124 | 0.255 | Prostaglandin dehydrogenase inhibitor | 0.182 0.171 CID_36332 | ||
| 0.167 | 0.038 | 0.167 | Adenylate cyclase stimulant | |||
| 0.181 | 0.053 | 0.181 | Phospholipase A2 inhibitor | 0.178 0.055 CID_36332 | ||
| 0.133 | 0.006 | 0.133 | Potassium channel (ATP-sensitive) blocker | 0.103 0.014 CID_36332 | ||
| 0.145 | 0.019 | 0.145 | Phosphofructokinase-1 inhibitor | 0.07 0.048 CID_36332 | ||
| 0.132 | 0.006 | 0.132 | NMDA receptor subunit 3A antagonist | 0.057 0.017 CID_36332 | ||
| 0.146 | 0.021 | 0.159 | Electrolyte absorption antagonist | 0.159 0.016 CID_36332 | CID_36332 | |
| 0.291 | 0.166 | 0.477 | DNA directed DNA polymerase inhibitor | 0.477 0.089 CID_36332 | CID_36332 | |
| 0.129 | 0.005 | 0.129 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.083 0.032 CID_36332 | ||
| 0.135 | 0.011 | 0.135 | Biliverdin reductase inhibitor | 0.084 0.024 CID_36332 | ||
| 0.25 | 0.127 | 0.25 | Transcription factor NF kappa B inhibitor | 0.24 0.135 CID_36332 | ||
| 0.139 | 0.016 | 0.139 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.13 | 0.01 | 0.13 | Granulocyte macrophage colony stimulating factor agonist | 0.086 0.061 CID_36332 | ||
| 0.139 | 0.02 | 0.139 | NADH dehydrogenase inhibitor | 0.084 0.066 CID_36332 | ||
| 0.154 | 0.036 | 0.154 | Aminopeptidase B inhibitor | 0.117 0.054 CID_36332 | ||
| 0.148 | 0.029 | 0.17 | UDP-glucose 4-epimerase inhibitor | 0.17 0.023 CID_36332 | CID_36332 | |
| 0.138 | 0.02 | 0.138 | CYP2A6 inhibitor | |||
| 0.126 | 0.008 | 0.126 | Estrogen-related receptor beta agonist | 0.088 0.046 CID_36332 | ||
| 0.172 | 0.055 | 0.172 | Cyclooxygenase inhibitor | |||
| 0.145 | 0.028 | 0.203 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.203 0.015 CID_36332 | CID_36332 | |
| 0.142 | 0.026 | 0.142 | DOPA decarboxylase inhibitor | 0.096 0.084 CID_36332 | ||
| 0.154 | 0.038 | 0.159 | Heat shock protein 70 antagonist | 0.159 0.03 CID_36332 | CID_36332 | |
| 0.219 | 0.106 | 0.219 | Spasmolytic | |||
| 0.16 | 0.047 | 0.175 | Sphingosine 1-phosphate receptor 5 antagonist | 0.175 0.029 CID_36332 | CID_36332 | |
| 0.141 | 0.028 | 0.141 | Creatine kinase inhibitor | 0.092 0.069 CID_36332 | ||
| 0.138 | 0.026 | 0.138 | Acetylcholine release stimulant | 0.113 0.06 CID_36332 | ||
| 0.128 | 0.016 | 0.128 | Phenylalanine 4-hydroxylase inhibitor | 0.075 0.041 CID_36332 | ||
| 0.134 | 0.022 | 0.134 | Histidine decarboxylase inhibitor | |||
| 0.124 | 0.013 | 0.124 | Alcohol oxidase inhibitor | 0.093 0.02 CID_36332 | ||
| 0.149 | 0.038 | 0.149 | Microtubule formation inhibitor | 0.109 0.075 CID_36332 | ||
| 0.157 | 0.046 | 0.157 | Glutamate receptor antagonist | |||
| 0.195 | 0.085 | 0.195 | MAP kinase kinase 2 inhibitor | 0.141 0.13 CID_36332 | ||
| 0.133 | 0.026 | 0.133 | Triose-phosphate isomerase inhibitor | 0.124 0.03 CID_36332 | ||
| 0.129 | 0.024 | 0.129 | Histamine N-methyltransferase inhibitor | |||
| 0.115 | 0.011 | 0.115 | Alpha 2 adrenoreceptor agonist | 0.074 0.028 CID_36332 | ||
| 0.189 | 0.085 | 0.191 | Insulin sensitizer | 0.191 0.083 CID_36332 | CID_36332 | |
| 0.144 | 0.04 | 0.19 | Papain-like protease (SARS coronavirus) inhibitor | 0.19 0.013 CID_36332 | CID_36332 | |
| 0.122 | 0.018 | 0.122 | Bile acid receptor antagonist | 0.111 0.03 CID_36332 | ||
| 0.187 | 0.086 | 0.187 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.197 | 0.096 | 0.197 | Angiogenesis stimulant | |||
| 0.156 | 0.056 | 0.156 | Neuropeptide Y1 antagonist | 0.156 0.056 CID_36332 | ||
| 0.117 | 0.018 | 0.117 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.175 | 0.076 | 0.175 | Amyloid beta precursor protein antagonist | |||
| 0.119 | 0.022 | 0.119 | Glutamate release inhibitor | |||
| 0.141 | 0.045 | 0.141 | Cystathionine beta-synthase inhibitor | |||
| 0.109 | 0.014 | 0.109 | Purinergic P2X1 antagonist | 0.054 0.053 CID_36332 | ||
| 0.262 | 0.166 | 0.262 | Antibacterial | |||
| 0.11 | 0.017 | 0.11 | Argininosuccinate synthase inhibitor | |||
| 0.203 | 0.11 | 0.264 | Calpain inhibitor | 0.264 0.053 CID_36332 | CID_36332 | |
| 0.097 | 0.004 | 0.097 | Endothelial nitric-oxide synthase inhibitor | 0.03 0.023 CID_36332 | ||
| 0.233 | 0.141 | 0.255 | Antithrombotic | 0.255 0.122 CID_36332 | CID_36332 | |
| 0.111 | 0.019 | 0.111 | D-Ala-D-Ala ligase inhibitor | 0.086 0.052 CID_36332 | ||
| 0.14 | 0.049 | 0.14 | Vanilloid 1 agonist | 0.134 0.059 CID_36332 | ||
| 0.12 | 0.029 | 0.12 | Carbonic anhydrase VI inhibitor | 0.092 0.045 CID_36332 | ||
| 0.123 | 0.033 | 0.123 | Alcohol dehydrogenase inhibitor | 0.092 0.062 CID_36332 | ||
| 0.104 | 0.013 | 0.104 | Androgen agonist | 0.085 0.021 CID_36332 | ||
| 0.228 | 0.138 | 0.417 | Thyroid hormone antagonist | 0.417 0.051 CID_36332 | CID_36332 | |
| 0.125 | 0.035 | 0.125 | Anabolic | 0.114 0.046 CID_36332 | ||
| 0.123 | 0.036 | 0.123 | Folate antagonist | |||
| 0.153 | 0.066 | 0.153 | Protein kinase stimulant | 0.113 0.101 CID_36332 | ||
| 0.119 | 0.034 | 0.15 | Androgen antagonist | 0.15 0.023 CID_36332 | CID_36332 | |
| 0.09 | 0.005 | 0.09 | Fructose-1,6-bisphosphatase inhibitor | 0.061 0.017 CID_36332 | ||
| 0.101 | 0.016 | 0.14 | NMDA receptor glycine site agonist | 0.14 0.005 CID_36332 | CID_36332 | |
| 0.13 | 0.045 | 0.13 | Transcription factor STAT6 inhibitor | 0.121 0.058 CID_36332 | ||
| 0.139 | 0.055 | 0.139 | Aldehyde dehydrogenase inhibitor | |||
| 0.108 | 0.027 | 0.108 | Glutamate dehydrogenase inhibitor | 0.08 0.045 CID_36332 | ||
| 0.086 | 0.004 | 0.086 | Dihydrofolate reductase inhibitor | 0.046 0.024 CID_36332 | ||
| 0.086 | 0.006 | 0.086 | Adenylate cyclase 1 inhibitor | 0.06 0.018 CID_36332 | ||
| 0.092 | 0.013 | 0.104 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.104 0.009 CID_36332 | CID_36332 | |
| 0.115 | 0.036 | 0.136 | Potassium channel (Voltage-sensitive) activator | 0.136 0.019 CID_36332 | CID_36332 | |
| 0.122 | 0.043 | 0.127 | Carbonic anhydrase III inhibitor | 0.127 0.04 CID_36332 | CID_36332 | |
| 0.098 | 0.02 | 0.143 | NMDA receptor agonist | 0.143 0.009 CID_36332 | CID_36332 | |
| 0.111 | 0.033 | 0.111 | Alpha 2d adrenoreceptor antagonist | 0.102 0.046 CID_36332 | ||
| 0.151 | 0.073 | 0.151 | Acetylcholine M1 receptor antagonist | |||
| 0.095 | 0.017 | 0.095 | Acyl-CoA dehydrogenase inhibitor | 0.056 0.036 CID_36332 | ||
| 0.092 | 0.015 | 0.092 | Glutamate (mGluR6) antagonist | 0.062 0.06 CID_36332 | ||
| 0.102 | 0.027 | 0.102 | Aminopeptidase I inhibitor | 0.084 0.039 CID_36332 | ||
| 0.086 | 0.01 | 0.086 | Calcium channel P-type blocker | |||
| 0.125 | 0.05 | 0.125 | MAO A inhibitor | 0.107 0.06 CID_36332 | ||
| 0.079 | 0.004 | 0.079 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.026 CID_36332 | ||
| 0.151 | 0.076 | 0.151 | Diuretic | 0.115 0.111 CID_36332 | ||
| 0.178 | 0.103 | 0.178 | Histone acetyltransferase inhibitor | |||
| 0.151 | 0.076 | 0.151 | Interferon gamma antagonist | 0.138 0.097 CID_36332 | ||
| 0.095 | 0.021 | 0.095 | Secretase beta inhibitor | 0.085 0.03 CID_36332 | ||
| 0.131 | 0.058 | 0.131 | Alkylator | 0.111 0.077 CID_36332 | ||
| 0.129 | 0.056 | 0.158 | Interleukin 1b antagonist | 0.158 0.035 CID_36332 | CID_36332 | |
| 0.167 | 0.094 | 0.167 | MAP kinase kinase 5 inhibitor | |||
| 0.215 | 0.142 | 0.412 | Thyroid hormone beta antagonist | 0.412 0.05 CID_36332 | CID_36332 | |
| 0.144 | 0.073 | 0.144 | Protein kinase C nu inhibitor | |||
| 0.139 | 0.068 | 0.139 | Nav1.6 sodium channel blocker | |||
| 0.107 | 0.037 | 0.107 | Ornithine decarboxylase inhibitor | |||
| 0.084 | 0.013 | 0.084 | NMDA receptor subunit 3B antagonist | 0.069 0.016 CID_36332 | ||
| 0.097 | 0.028 | 0.102 | Adenosine A3 receptor antagonist | 0.102 0.025 CID_36332 | CID_36332 | |
| 0.17 | 0.1 | 0.17 | Pyruvate kinase inhibitor | |||
| 0.257 | 0.188 | 0.459 | DNA polymerase beta inhibitor | 0.459 0.098 CID_36332 | CID_36332 | |
| 0.157 | 0.089 | 0.157 | Catenin beta inhibitor | 0.145 0.118 CID_36332 | ||
| 0.078 | 0.01 | 0.078 | Kainate receptor antagonist | |||
| 0.098 | 0.03 | 0.098 | Interferon agonist | |||
| 0.079 | 0.011 | 0.114 | Dihydroorotate oxidase inhibitor | 0.114 0.004 CID_36332 | CID_36332 | |
| 0.074 | 0.006 | 0.074 | Potassium channel Kv1.1 blocker | 0.065 0.007 CID_36332 | ||
| 0.076 | 0.008 | 0.076 | Estrogen-related receptor alpha antagonist | |||
| 0.083 | 0.015 | 0.09 | Sphingosine 1-phosphate receptor 3 antagonist | 0.09 0.011 CID_36332 | CID_36332 | |
| 0.084 | 0.017 | 0.084 | Phosphodiesterase 1C inhibitor | 0.063 0.04 CID_36332 | ||
| 0.091 | 0.024 | 0.091 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.1 | 0.033 | 0.129 | Glycine receptor antagonist | 0.129 0.014 CID_36332 | CID_36332 | |
| 0.101 | 0.034 | 0.101 | Myeloperoxidase inhibitor | |||
| 0.098 | 0.031 | 0.098 | Glutamate decarboxylase inhibitor | |||
| 0.073 | 0.006 | 0.073 | Geranyltranstransferase inhibitor | 0.042 0.033 CID_36332 | ||
| 0.127 | 0.06 | 0.127 | DNA repair enzyme inhibitor | 0.107 0.104 CID_36332 | ||
| 0.137 | 0.071 | 0.137 | Amylase inhibitor | |||
| 0.116 | 0.049 | 0.137 | Urease inhibitor | 0.137 0.031 CID_36332 | CID_36332 | |
| 0.082 | 0.017 | 0.082 | MDM2 inhibitor | |||
| 0.084 | 0.019 | 0.106 | Acetyl-CoA transferase inhibitor | 0.106 0.011 CID_36332 | CID_36332 | |
| 0.148 | 0.084 | 0.148 | Melanin inhibitor | 0.131 0.113 CID_36332 | ||
| 0.089 | 0.026 | 0.089 | MAP kinase kinase 7 inhibitor | 0.076 0.058 CID_36332 | ||
| 0.071 | 0.008 | 0.071 | AMPA 4 receptor antagonist | |||
| 0.085 | 0.022 | 0.085 | Glutamate (mGluR7) antagonist | |||
| 0.202 | 0.138 | 0.202 | Lipoxygenase inhibitor | |||
| 0.119 | 0.056 | 0.127 | Mucolytic | 0.127 0.048 CID_36332 | CID_36332 | |
| 0.072 | 0.01 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.062 0.021 CID_36332 | ||
| 0.166 | 0.105 | 0.173 | Focal adhesion kinase 2 inhibitor | 0.173 0.096 CID_36332 | CID_36332 | |
| 0.072 | 0.011 | 0.072 | Sodium/calcium exchanger inhibitor | |||
| 0.075 | 0.015 | 0.075 | Potassium channel (Inward rectifier) blocker | 0.053 0.031 CID_36332 | ||
| 0.104 | 0.044 | 0.104 | Thioredoxin inhibitor | |||
| 0.107 | 0.047 | 0.138 | Glutamate (mGluR7) agonist | 0.138 0.017 CID_36332 | CID_36332 | |
| 0.068 | 0.009 | 0.068 | Dopamine D5 agonist | |||
| 0.088 | 0.03 | 0.088 | Glycine receptor agonist | |||
| 0.13 | 0.072 | 0.13 | Nav1.2 sodium channel blocker | 0.107 0.1 CID_36332 | ||
| 0.097 | 0.039 | 0.097 | Adrenaline agonist | 0.086 0.05 CID_36332 | ||
| 0.069 | 0.012 | 0.069 | Thymidylate synthase inhibitor | |||
| 0.08 | 0.024 | 0.08 | Interferon inducer | |||
| 0.075 | 0.018 | 0.075 | Sphingosine kinase 2 inhibitor | |||
| 0.065 | 0.009 | 0.065 | Cytokine production stimulant | 0.047 0.036 CID_36332 | ||
| 0.077 | 0.022 | 0.077 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.065 | 0.01 | 0.065 | Dihydropteroate synthase inhibitor | 0.051 0.016 CID_36332 | ||
| 0.105 | 0.05 | 0.105 | Prolactin inhibitor | |||
| 0.176 | 0.122 | 0.176 | ErbB-1 antagonist | |||
| 0.101 | 0.047 | 0.161 | Potassium channel activator | 0.161 0.017 CID_36332 | CID_36332 | |
| 0.078 | 0.025 | 0.078 | Glutamate (mGluR1) antagonist | |||
| 0.07 | 0.018 | 0.07 | Aconitate hydratase inhibitor | |||
| 0.059 | 0.007 | 0.059 | Glutamate (mGluR8) agonist | 0.044 0.017 CID_36332 | ||
| 0.129 | 0.077 | 0.154 | Sphingosine 1-phosphate receptor 2 antagonist | 0.154 0.036 CID_36332 | CID_36332 | |
| 0.088 | 0.036 | 0.088 | Purinergic P2X2 antagonist | |||
| 0.085 | 0.033 | 0.085 | GABA B receptor agonist | 0.08 0.043 CID_36332 | ||
| 0.069 | 0.018 | 0.069 | Ryanodine receptor antagonist | |||
| 0.093 | 0.042 | 0.093 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.069 | 0.018 | 0.069 | H+/K+-transporting ATPase inhibitor | |||
| 0.07 | 0.019 | 0.07 | Beta 2 adrenoreceptor agonist | 0.066 0.029 CID_36332 | ||
| 0.111 | 0.06 | 0.166 | Falcipain 3 inhibitor | 0.166 0.03 CID_36332 | CID_36332 | |
| 0.085 | 0.035 | 0.085 | Alpha adrenoreceptor agonist | |||
| 0.073 | 0.024 | 0.093 | Histone deacetylase SIRT3 inhibitor | 0.093 0.012 CID_36332 | CID_36332 | |
| 0.09 | 0.04 | 0.09 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.078 | 0.029 | 0.078 | Adenosine A1 receptor antagonist | |||
| 0.058 | 0.01 | 0.058 | Histamine H1 receptor agonist | 0.046 0.025 CID_36332 | ||
| 0.062 | 0.014 | 0.062 | Histamine H2 receptor agonist | 0.046 0.025 CID_36332 | ||
| 0.097 | 0.049 | 0.099 | Polo-like kinase-1 inhibitor | 0.099 0.047 CID_36332 | CID_36332 | |
| 0.073 | 0.025 | 0.073 | Transcription factor RelA inhibitor | |||
| 0.114 | 0.066 | 0.133 | TRPA1 agonist | 0.133 0.045 CID_36332 | CID_36332 | |
| 0.113 | 0.066 | 0.113 | Monophenol monooxygenase inhibitor | |||
| 0.18 | 0.134 | 0.18 | DNA damaging | |||
| 0.064 | 0.018 | 0.064 | Adenosine deaminase inhibitor | |||
| 0.078 | 0.033 | 0.078 | Histone deacetylase inhibitor | 0.067 0.043 CID_36332 | ||
| 0.102 | 0.057 | 0.102 | Sphingomyelinase inhibitor | 0.084 0.08 CID_36332 | ||
| 0.065 | 0.02 | 0.065 | Beta 2 adrenoreceptor antagonist | 0.06 0.024 CID_36332 | ||
| 0.071 | 0.027 | 0.071 | Carbonic anhydrase VB inhibitor | 0.062 0.033 CID_36332 | ||
| 0.062 | 0.018 | 0.071 | Potassium channel (Inward rectifier) activator | 0.071 0.011 CID_36332 | CID_36332 | |
| 0.106 | 0.062 | 0.106 | Expectorant | 0.101 0.067 CID_36332 | ||
| 0.095 | 0.051 | 0.095 | Phosphodiesterase I inhibitor | |||
| 0.055 | 0.012 | 0.055 | Vascular adhesion protein 1 inhibitor | |||
| 0.088 | 0.044 | 0.088 | Carbonic anhydrase XIII inhibitor | 0.073 0.055 CID_36332 | ||
| 0.067 | 0.024 | 0.067 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.052 0.04 CID_36332 | ||
| 0.047 | 0.004 | 0.047 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.023 0.017 CID_36332 | ||
| 0.055 | 0.013 | 0.12 | Nicotinic acid receptor agonist | 0.12 0.004 CID_36332 | CID_36332 | |
| 0.059 | 0.017 | 0.068 | Potassium channel (ATP-sensitive) activator | 0.068 0.011 CID_36332 | CID_36332 | |
| 0.09 | 0.048 | 0.09 | mTOR complex 2 inhibitor | |||
| 0.132 | 0.092 | 0.132 | Hemostatic | |||
| 0.049 | 0.009 | 0.049 | AMPA 3 receptor antagonist | |||
| 0.073 | 0.034 | 0.073 | 5 Hydroxytryptamine 2A agonist | |||
| 0.074 | 0.035 | 0.074 | Exportin-1 inhibitor | |||
| 0.069 | 0.03 | 0.08 | Cyclin D1 inhibitor | 0.08 0.018 CID_36332 | CID_36332 | |
| 0.043 | 0.004 | 0.044 | Imidazoline I1 receptor antagonist | 0.044 0.004 CID_36332 | CID_36332 | |
| 0.081 | 0.043 | 0.11 | Sphingosine 1-phosphate receptor antagonist | 0.11 0.017 CID_36332 | CID_36332 | |
| 0.085 | 0.048 | 0.103 | CC chemokine 5 receptor agonist | 0.103 0.018 CID_36332 | CID_36332 | |
| 0.153 | 0.115 | 0.309 | Interleukin antagonist | 0.309 0.046 CID_36332 | CID_36332 | |
| 0.053 | 0.017 | 0.053 | Thymidine kinase inhibitor | 0.042 0.027 CID_36332 | ||
| 0.175 | 0.138 | 0.254 | Peptidyltransferase inhibitor | 0.254 0.048 CID_36332 | CID_36332 | |
| 0.059 | 0.023 | 0.059 | Topoisomerase II beta inhibitor | 0.054 0.028 CID_36332 | ||
| 0.043 | 0.007 | 0.054 | NMDA receptor glycine site antagonist | 0.054 0.005 CID_36332 | CID_36332 | |
| 0.062 | 0.026 | 0.062 | Lysine-specific demethylase 1A inhibitor | |||
| 0.05 | 0.014 | 0.054 | Diamine oxidase inhibitor | 0.054 0.012 CID_36332 | CID_36332 | |
| 0.067 | 0.031 | 0.067 | Heat shock protein 90 beta antagonist | |||
| 0.094 | 0.059 | 0.094 | ABCA1 expression enhancer | |||
| 0.096 | 0.061 | 0.096 | MAP kinase kinase 1 inhibitor | |||
| 0.06 | 0.025 | 0.06 | AMPA receptor antagonist | |||
| 0.068 | 0.033 | 0.068 | Carbonic anhydrase stimulant | 0.064 0.037 CID_36332 | ||
| 0.053 | 0.019 | 0.053 | AICAR transformylase inhibitor | 0.048 0.025 CID_36332 | ||
| 0.061 | 0.027 | 0.061 | Epithelial sodium channel blocker | |||
| 0.144 | 0.11 | 0.173 | DNA methyltransferase I inhibitor | 0.173 0.084 CID_36332 | CID_36332 | |
| 0.05 | 0.016 | 0.05 | GABA uptake inhibitor | |||
| 0.049 | 0.015 | 0.049 | Kainate receptor agonist | |||
| 0.119 | 0.085 | 0.119 | Toll-Like receptor antagonist | |||
| 0.125 | 0.092 | 0.134 | Farnesoid X receptor antagonist | 0.134 0.074 CID_36332 | CID_36332 | |
| 0.061 | 0.029 | 0.061 | Pregnane X receptor antagonist | 0.053 0.05 CID_36332 | ||
| 0.048 | 0.016 | 0.048 | Heme oxygenase inhibitor | |||
| 0.193 | 0.161 | 0.193 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.064 | 0.033 | 0.064 | Sphingosine kinase inhibitor | 0.056 0.048 CID_36332 | ||
| 0.059 | 0.028 | 0.059 | Alpha-mannosidase inhibitor | 0.051 0.043 CID_36332 | ||
| 0.231 | 0.2 | 0.383 | Transcription factor inhibitor | 0.383 0.116 CID_36332 | CID_36332 | |
| 0.042 | 0.011 | 0.042 | Complement C5a chemotactic receptor antagonist | 0.029 0.022 CID_36332 | ||
| 0.117 | 0.086 | 0.138 | NADPH oxidase inhibitor | 0.138 0.064 CID_36332 | CID_36332 | |
| 0.047 | 0.016 | 0.047 | Inosine monophosphate dehydrogenase inhibitor | 0.042 0.02 CID_36332 | ||
| 0.057 | 0.026 | 0.066 | Lysophosphatidic acid 3 receptor antagonist | 0.066 0.018 CID_36332 | CID_36332 | |
| 0.094 | 0.065 | 0.094 | Phosphodiesterase 6D inhibitor | |||
| 0.066 | 0.037 | 0.066 | Aromatase inhibitor | |||
| 0.049 | 0.02 | 0.049 | Histone deacetylase class I inhibitor | 0.04 0.027 CID_36332 | ||
| 0.048 | 0.02 | 0.048 | Angiotensin AT1 receptor antagonist | 0.043 0.027 CID_36332 | ||
| 0.117 | 0.089 | 0.117 | Toll-Like receptor 9 antagonist | |||
| 0.149 | 0.121 | 0.149 | I kappa B kinase epsilon inhibitor | |||
| 0.072 | 0.044 | 0.083 | Carbonic anhydrase VA inhibitor | 0.083 0.034 CID_36332 | CID_36332 | |
| 0.04 | 0.012 | 0.04 | Uridine phosphorylase inhibitor | 0.028 0.02 CID_36332 | ||
| 0.035 | 0.008 | 0.035 | DNA polymerase III inhibitor | 0.03 0.016 CID_36332 | ||
| 0.045 | 0.018 | 0.045 | 5 Hydroxytryptamine 2B agonist | |||
| 0.068 | 0.041 | 0.068 | Beta adrenoreceptor antagonist | 0.068 0.041 CID_36332 | ||
| 0.053 | 0.026 | 0.053 | Aldosterone antagonist | 0.043 0.041 CID_36332 | ||
| 0.031 | 0.005 | 0.031 | Alpha 2c adrenoreceptor agonist | 0.029 0.005 CID_36332 | ||
| 0.048 | 0.022 | 0.048 | GABA B receptor antagonist | |||
| 0.078 | 0.052 | 0.078 | Estrogen receptor alpha antagonist | |||
| 0.035 | 0.008 | 0.042 | Nicotinic acid receptor 2 antagonist | 0.042 0.005 CID_36332 | CID_36332 | |
| 0.064 | 0.037 | 0.064 | Phosphodiesterase 1B inhibitor | |||
| 0.059 | 0.032 | 0.059 | Ornithine carbamoyltransferase inhibitor | |||
| 0.066 | 0.04 | 0.066 | 5 Hydroxytryptamine 3 agonist | |||
| 0.029 | 0.005 | 0.029 | Alpha 2b adrenoreceptor agonist | 0.023 0.007 CID_36332 | ||
| 0.066 | 0.041 | 0.079 | Beta 3 adrenoreceptor antagonist | 0.079 0.024 CID_36332 | CID_36332 | |
| 0.097 | 0.074 | 0.097 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.072 | 0.049 | 0.072 | Phospholipase D inhibitor | |||
| 0.038 | 0.015 | 0.038 | AMPA 1 receptor antagonist | |||
| 0.062 | 0.039 | 0.062 | Acetylcholine M5 receptor antagonist | |||
| 0.069 | 0.046 | 0.069 | Cyclin B3 inhibitor | |||
| 0.111 | 0.089 | 0.111 | Tubulin antagonist | |||
| 0.04 | 0.018 | 0.04 | Fumarate hydratase inhibitor | |||
| 0.043 | 0.022 | 0.043 | Alpha 1d adrenoreceptor agonist | 0.034 0.033 CID_36332 | ||
| 0.04 | 0.02 | 0.04 | Retinoid X alpha receptor agonist | |||
| 0.044 | 0.024 | 0.053 | Acetyl-CoA transferase 1 inhibitor | 0.053 0.014 CID_36332 | CID_36332 | |
| 0.032 | 0.012 | 0.032 | Estrogen-related receptor gamma antagonist | |||
| 0.105 | 0.085 | 0.105 | M18 aspartyl aminopeptidase inhibitor | 0.098 0.094 CID_36332 | ||
| 0.026 | 0.006 | 0.045 | Neuraminidase (Influenza B) inhibitor | 0.045 0.003 CID_36332 | CID_36332 | |
| 0.05 | 0.03 | 0.05 | Dopamine beta hydroxylase inhibitor | |||
| 0.03 | 0.01 | 0.03 | Acid ceramidase inhibitor | 0.024 0.023 CID_36332 | ||
| 0.046 | 0.026 | 0.046 | Oxytocin agonist | |||
| 0.12 | 0.1 | 0.21 | Cytidine deaminase inhibitor | 0.21 0.043 CID_36332 | CID_36332 | |
| 0.033 | 0.013 | 0.033 | Purinergic P2Y15 antagonist | 0.028 0.02 CID_36332 | ||
| 0.03 | 0.011 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.016 CID_36332 | ||
| 0.048 | 0.028 | 0.048 | Mannosidase inhibitor | |||
| 0.064 | 0.045 | 0.071 | Protease 3C (Human rhinovirus) inhibitor | 0.071 0.036 CID_36332 | CID_36332 | |
| 0.115 | 0.096 | 0.115 | Interleukin 1 antagonist | 0.115 0.095 CID_36332 | ||
| 0.071 | 0.052 | 0.071 | Cathepsin G inhibitor | |||
| 0.034 | 0.015 | 0.034 | Elastase 3B inhibitor | 0.03 0.024 CID_36332 | ||
| 0.034 | 0.015 | 0.034 | Elastase 3A inhibitor | 0.03 0.024 CID_36332 | ||
| 0.034 | 0.015 | 0.034 | Elastase 2B inhibitor | 0.03 0.024 CID_36332 | ||
| 0.025 | 0.007 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 CID_36332 | ||
| 0.086 | 0.068 | 0.086 | Potassium channel (Ca-activated) activator | |||
| 0.065 | 0.047 | 0.079 | Carbonic anhydrase V inhibitor | 0.079 0.036 CID_36332 | CID_36332 | |
| 0.076 | 0.059 | 0.076 | Acetylcholine nicotinic antagonist | |||
| 0.028 | 0.011 | 0.028 | Complement factor 1s inhibitor | |||
| 0.024 | 0.006 | 0.024 | Estrogen-related receptor gamma agonist | 0.018 0.015 CID_36332 | ||
| 0.033 | 0.016 | 0.033 | Sigma 1 receptor antagonist | |||
| 0.052 | 0.035 | 0.064 | Factor IXa inhibitor | 0.064 0.024 CID_36332 | CID_36332 | |
| 0.1 | 0.083 | 0.1 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.039 | 0.023 | 0.059 | Potassium channel KCNQ activator | 0.059 0.011 CID_36332 | CID_36332 | |
| 0.039 | 0.023 | 0.059 | Delayed rectifier potassium channel activator | 0.059 0.011 CID_36332 | CID_36332 | |
| 0.037 | 0.02 | 0.053 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.053 0.008 CID_36332 | CID_36332 | |
| 0.046 | 0.03 | 0.046 | Purinergic P2Y antagonist | |||
| 0.039 | 0.022 | 0.039 | Glutamate (mGluR3) antagonist | |||
| 0.041 | 0.025 | 0.041 | Urate transporter 1 inhibitor | |||
| 0.034 | 0.018 | 0.034 | Glutamate (mGluR3) agonist | |||
| 0.04 | 0.024 | 0.04 | Retinoid X receptor antagonist | |||
| 0.141 | 0.126 | 0.16 | DNA methylase inhibitor | 0.16 0.109 CID_36332 | CID_36332 | |
| 0.041 | 0.025 | 0.041 | Membrane dipeptidase inhibitor | 0.037 0.032 CID_36332 | ||
| 0.037 | 0.022 | 0.037 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.036 | 0.021 | 0.036 | Angiotensin II receptor antagonist | 0.031 0.03 CID_36332 | ||
| 0.036 | 0.021 | 0.036 | Retinoid X alpha receptor antagonist | |||
| 0.022 | 0.008 | 0.022 | Alpha 2a adrenoreceptor agonist | |||
| 0.022 | 0.008 | 0.022 | Antibiotic Anthracycline-like | |||
| 0.09 | 0.076 | 0.09 | Alpha 2c adrenoreceptor antagonist | |||
| 0.023 | 0.009 | 0.023 | Toll-Like receptor 8 agonist | |||
| 0.047 | 0.034 | 0.047 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.041 CID_36332 | ||
| 0.042 | 0.03 | 0.042 | Guanylate cyclase inhibitor | |||
| 0.049 | 0.037 | 0.049 | Diacylglycerol O-acyltransferase inhibitor | 0.047 0.04 CID_36332 | ||
| 0.017 | 0.005 | 0.017 | DNA polymerase III polC-type inhibitor | 0.014 0.008 CID_36332 | ||
| 0.014 | 0.003 | 0.014 | DNA topoisomerase III inhibitor | 0.011 0.003 CID_36332 | ||
| 0.042 | 0.031 | 0.06 | Carbonic anhydrase IV inhibitor | 0.06 0.019 CID_36332 | CID_36332 | |
| 0.072 | 0.062 | 0.072 | Keratolytic | |||
| 0.03 | 0.02 | 0.035 | Purinergic P2Y14 antagonist | 0.035 0.015 CID_36332 | CID_36332 | |
| 0.044 | 0.034 | 0.044 | Beta adrenoreceptor agonist | |||
| 0.047 | 0.037 | 0.047 | CC chemokine receptor 2B antagonist | |||
| 0.029 | 0.019 | 0.042 | Cyclin E2 inhibitor | 0.042 0.011 CID_36332 | CID_36332 | |
| 0.078 | 0.068 | 0.078 | Alpha 2 adrenoreceptor antagonist | |||
| 0.059 | 0.049 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.05 | 0.04 | 0.05 | Alpha tubulin antagonist | |||
| 0.122 | 0.112 | 0.122 | Sigma receptor agonist | |||
| 0.067 | 0.058 | 0.164 | Catalase inhibitor | 0.164 0.023 CID_36332 | CID_36332 | |
| 0.089 | 0.079 | 0.089 | Insulin receptor antagonist | |||
| 0.082 | 0.073 | 0.082 | Pim-3 kinase inhibitor | |||
| 0.046 | 0.038 | 0.046 | Carbonic anhydrase XIV inhibitor | |||
| 0.051 | 0.043 | 0.051 | GABA receptor antagonist | |||
| 0.025 | 0.017 | 0.025 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.072 | 0.064 | 0.072 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.054 | 0.046 | 0.088 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.088 0.021 CID_36332 | CID_36332 | |
| 0.092 | 0.084 | 0.126 | Protein kinase (CK2) alpha inhibitor | 0.126 0.058 CID_36332 | CID_36332 | |
| 0.04 | 0.033 | 0.046 | Leukocyte elastase inhibitor | 0.046 0.026 CID_36332 | CID_36332 | |
| 0.12 | 0.113 | 0.12 | Protein-tyrosine phosphatase inhibitor | |||
| 0.054 | 0.047 | 0.06 | Leukotriene C antagonist | 0.06 0.03 CID_36332 | CID_36332 | |
| 0.018 | 0.011 | 0.018 | Ileal bile acid transport inhibitor | 0.016 0.013 CID_36332 | ||
| 0.016 | 0.009 | 0.016 | NMDA receptor phencyclidine site antagonist | |||
| 0.049 | 0.042 | 0.049 | Toll-Like receptor 8 antagonist | |||
| 0.033 | 0.026 | 0.033 | Phosphoglycerate kinase inhibitor | |||
| 0.057 | 0.05 | 0.057 | Phosphodiesterase 1A inhibitor | |||
| 0.021 | 0.014 | 0.021 | Retinoid X beta receptor antagonist | |||
| 0.018 | 0.012 | 0.018 | Complement factor D inhibitor | |||
| 0.042 | 0.035 | 0.042 | Glutamate (mGluR group III) antagonist | |||
| 0.025 | 0.018 | 0.025 | Vanilloid 2 agonist | |||
| 0.04 | 0.033 | 0.04 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.033 | 0.027 | 0.033 | Retinoid X receptor agonist | |||
| 0.027 | 0.021 | 0.027 | Thrombin receptor antagonist | |||
| 0.033 | 0.027 | 0.033 | Growth hormone secretagogue receptor antagonist | |||
| 0.049 | 0.043 | 0.049 | GABA A receptor antagonist | |||
| 0.047 | 0.041 | 0.047 | Squalene epoxidase inhibitor | |||
| 0.018 | 0.012 | 0.03 | Nicotinic acid receptor 1 antagonist | 0.03 0.004 CID_36332 | CID_36332 | |
| 0.011 | 0.006 | 0.011 | Angiotensin AT2 receptor agonist | |||
| 0.012 | 0.006 | 0.012 | Imidazoline I2 receptor antagonist | 0.01 0.009 CID_36332 | ||
| 0.042 | 0.037 | 0.048 | Glycine transporter 2 inhibitor | 0.048 0.032 CID_36332 | CID_36332 | |
| 0.07 | 0.065 | 0.07 | Potassium channel (Tandem pore domain) blocker | |||
| 0.025 | 0.02 | 0.025 | Thymidine phosphorylase inhibitor | |||
| 0.055 | 0.051 | 0.055 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.029 | 0.024 | 0.029 | Potassium channel small-conductance Ca-activated activator | |||
| 0.019 | 0.014 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.05 | 0.045 | 0.05 | Leukotriene B4 antagonist | |||
| 0.086 | 0.082 | 0.086 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.021 | 0.017 | 0.021 | Glutamate (mGluR1a) agonist | |||
| 0.069 | 0.066 | 0.07 | Vanilloid 4 agonist | 0.07 0.064 CID_36332 | CID_36332 | |
| 0.04 | 0.037 | 0.04 | Glutamate (mGluR4) antagonist | |||
| 0.054 | 0.051 | 0.054 | Adenosine A2a receptor antagonist | |||
| 0.103 | 0.1 | 0.156 | Toll-Like receptor 2 antagonist | 0.156 0.048 CID_36332 | CID_36332 | |
| 0.025 | 0.022 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.044 | 0.041 | 0.046 | Benzodiazepine antagonist | 0.046 0.036 CID_36332 | CID_36332 | |
| 0.123 | 0.12 | 0.137 | Pregnane X receptor agonist | 0.137 0.08 CID_36332 | CID_36332 | |
| 0.045 | 0.042 | 0.045 | Histamine H4 receptor antagonist | |||
| 0.054 | 0.051 | 0.054 | Cyclin A1 inhibitor | |||
| 0.027 | 0.025 | 0.027 | Acetylcholine M4 receptor agonist | |||
| 0.023 | 0.021 | 0.023 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.021 CID_36332 | ||
| 0.021 | 0.019 | 0.021 | Histone deacetylase 1 inhibitor | |||
| 0.057 | 0.055 | 0.057 | Leukotriene antagonist | |||
| 0.024 | 0.021 | 0.024 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.023 | 0.021 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.015 | 0.014 | 0.015 | CDK2/cyclin A3 inhibitor | |||
| 0.024 | 0.022 | 0.025 | CXC chemokine 2 receptor antagonist | 0.025 0.02 CID_36332 | CID_36332 | |
| 0.15 | 0.148 | 0.15 | Antiamyloidogenic | |||
| 0.046 | 0.045 | 0.055 | CXC chemokine 1 receptor antagonist | 0.055 0.029 CID_36332 | CID_36332 | |
| 0.055 | 0.053 | 0.055 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.065 | 0.064 | 0.065 | Na+ K+ transporting ATPase inhibitor | |||
| 0.03 | 0.029 | 0.03 | Purinergic P2Y2 antagonist | |||
| 0.076 | 0.075 | 0.076 | Histamine H2 receptor antagonist | |||
| 0.096 | 0.095 | 0.096 | MAO inhibitor | |||
| 0.119 | 0.119 | 0.126 | Cyclin-dependent kinase 8 inhibitor | 0.126 0.109 CID_36332 | CID_36332 | |
| 0.035 | 0.035 | 0.044 | CC chemokine 3 receptor antagonist | 0.044 0.027 CID_36332 | CID_36332 | |
| 0.032 | 0.033 | 0.034 | Adenosine uptake inhibitor | 0.034 0.027 CID_36332 | CID_36332 | |
| 0.023 | 0.024 | 0.029 | Thyroid hormone agonist | 0.029 0.014 CID_36332 | CID_36332 | |
| 0.019 | 0.02 | 0.021 | Factor XIII inhibitor | 0.021 0.014 CID_36332 | CID_36332 | |
| 0.061 | 0.063 | 0.069 | Polo-like kinase-2 inhibitor | 0.069 0.054 CID_36332 | CID_36332 | |
| 0.047 | 0.051 | 0.052 | Beta 1 adrenoreceptor antagonist | 0.052 0.044 CID_36332 | CID_36332 | |
| 0.028 | 0.031 | 0.037 | Methionyl aminopeptidase 1 inhibitor | 0.037 0.015 CID_36332 | CID_36332 | |
| 0.05 | 0.056 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | 0.06 0.029 CID_36332 | CID_36332 | |
| 0.125 | 0.132 | 0.144 | Antipruritic | 0.144 0.102 CID_36332 | CID_36332 | |
| 0.047 | 0.053 | 0.053 | Nicotinic alpha3beta2 receptor antagonist | 0.053 0.037 CID_36332 | CID_36332 | |
| 0.029 | 0.036 | 0.034 | Melatonin receptor 1A agonist | 0.034 0.023 CID_36332 | CID_36332 | |
| 0.035 | 0.043 | 0.039 | Leukotriene C4 antagonist | 0.039 0.028 CID_36332 | CID_36332 | |
| 0.012 | 0.021 | 0.022 | Carbonic anhydrase VIII inhibitor | 0.022 0.007 CID_36332 | CID_36332 | |
| 0.012 | 0.021 | 0.022 | Carbonic anhydrase X inhibitor | 0.022 0.007 CID_36332 | CID_36332 | |
| 0.054 | 0.064 | 0.061 | Caspase 9 inhibitor | 0.061 0.045 CID_36332 | CID_36332 | |
| 0.045 | 0.058 | 0.052 | Cathepsin L inhibitor | 0.052 0.048 CID_36332 | CID_36332 | |
| 0.096 | 0.109 | 0.222 | M17 leucyl aminopeptidase inhibitor | 0.222 0.026 CID_36332 | CID_36332 | |
| 0.009 | 0.023 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.011 CID_36332 | CID_36332 | |
| 0.027 | 0.042 | 0.083 | Nicotinic acid receptor 2 agonist | 0.083 0.007 CID_36332 | CID_36332 | |
| 0.013 | 0.029 | 0.02 | Apolipoprotein B-100 inhibitor | 0.02 0.011 CID_36332 | CID_36332 | |
| 0.115 | 0.131 | 0.136 | Thiol protease inhibitor | 0.136 0.086 CID_36332 | CID_36332 | |
| 0.008 | 0.025 | 0.014 | Carbonic anhydrase XI inhibitor | 0.014 0.007 CID_36332 | CID_36332 | |
| 0.008 | 0.027 | 0.012 | Melatonin 2 antagonist | 0.012 0.009 CID_36332 | CID_36332 | |
| 0.023 | 0.043 | 0.043 | Epoxide hydrolase 1 inhibitor | 0.043 0.009 CID_36332 | CID_36332 | |
| 0.026 | 0.046 | 0.036 | Histone deacetylase 7 inhibitor | 0.036 0.027 CID_36332 | CID_36332 | |
| 0.031 | 0.054 | 0.047 | Carbonic anhydrase VII inhibitor | 0.047 0.031 CID_36332 | CID_36332 | |
| 0.03 | 0.054 | 0.037 | Histone deacetylase 9 inhibitor | 0.037 0.03 CID_36332 | CID_36332 | |
| 0.008 | 0.033 | 0.02 | Melatonin receptor 1A antagonist | 0.02 0.005 CID_36332 | CID_36332 | |
| 0.042 | 0.069 | 0.052 | Potassium channel Kv1.5 blocker | 0.052 0.046 CID_36332 | CID_36332 | |
| 0.167 | 0.194 | 0.239 | Transcription factor STAT inhibitor | 0.239 0.094 CID_36332 | CID_36332 | |
| 0.042 | 0.07 | 0.064 | Heparanase inhibitor | 0.064 0.017 CID_36332 | CID_36332 | |
| 0.033 | 0.062 | 0.095 | Neuraminidase (Influenza A) inhibitor | 0.095 0.004 CID_36332 | CID_36332 | |
| 0.014 | 0.045 | 0.021 | Protease (Human cytomegalovirus) inhibitor | 0.021 0.017 CID_36332 | CID_36332 | |
| 0.025 | 0.056 | 0.049 | Histone deacetylase 8 inhibitor | 0.049 0.022 CID_36332 | CID_36332 | |
| 0.035 | 0.067 | 0.043 | Purinergic P2X4 antagonist | 0.043 0.038 CID_36332 | CID_36332 | |
| 0.02 | 0.053 | 0.036 | Cyclophilin A inhibitor | 0.036 0.015 CID_36332 | CID_36332 | |
| 0.029 | 0.071 | 0.052 | Dihydroorotase inhibitor | 0.052 0.023 CID_36332 | CID_36332 | |
| 0.012 | 0.057 | 0.019 | Caspase 8 inhibitor | 0.019 0.015 CID_36332 | CID_36332 | |
| 0.026 | 0.074 | 0.062 | Nicotinic acid receptor 1 agonist | 0.062 0.015 CID_36332 | CID_36332 | |
| 0.08 | 0.132 | 0.129 | Caspase 3 inhibitor | 0.129 0.048 CID_36332 | CID_36332 | |
| 0.075 | 0.128 | 0.109 | Proteasome inhibitor | 0.109 0.076 CID_36332 | CID_36332 | |
| 0.161 | 0.214 | 0.413 | Beta lactamase inhibitor | 0.413 0.096 CID_36332 | CID_36332 | |
| 0.069 | 0.125 | 0.087 | Interleukin 1 beta converting enzyme inhibitor | 0.087 0.078 CID_36332 | CID_36332 | |
| 0.022 | 0.084 | 0.04 | CDK5/p25 inhibitor | 0.04 0.03 CID_36332 | CID_36332 | |
| 0.149 | 0.213 | 0.248 | Transcription factor STAT3 inhibitor | 0.248 0.085 CID_36332 | CID_36332 | |
| 0.073 | 0.136 | 0.123 | Nav1.3 sodium channel blocker | 0.123 0.071 CID_36332 | CID_36332 | |
| 0.05 | 0.115 | 0.074 | Acetylcholine nicotinic agonist | 0.074 0.066 CID_36332 | CID_36332 | |
| 0.026 | 0.092 | 0.059 | Dihydroorotate dehydrogenase inhibitor | 0.059 0.029 CID_36332 | CID_36332 | |
| 0.039 | 0.108 | 0.088 | Vanilloid antagonist | 0.088 0.041 CID_36332 | CID_36332 | |
| 0.114 | 0.184 | 0.159 | Hypolipemic | 0.159 0.128 CID_36332 | CID_36332 | |
| 0.147 | 0.224 | 0.268 | Thioredoxin glutathione reductase inhibitor | 0.268 0.123 CID_36332 | CID_36332 | |
| 0.057 | 0.14 | 0.086 | Breast cancer-resistant protein inhibitor | 0.086 0.071 CID_36332 | CID_36332 | |
| 0.033 | 0.12 | 0.054 | Fatty acid synthase inhibitor | 0.054 0.045 CID_36332 | CID_36332 | |
| 0.156 | 0.258 | 0.311 | Alpha-glucosidase inhibitor | 0.311 0.154 CID_36332 | CID_36332 | |
| 0.013 | 0.123 | 0.039 | Melatonin 2 agonist | 0.039 0.016 CID_36332 | CID_36332 | |
| 0.032 | 0.147 | 0.179 | Neuraminidase (influenza) inhibitor | 0.179 0.005 CID_36332 | CID_36332 | |
| 0.057 | 0.184 | 0.129 | Histone deacetylase class III inhibitor | 0.129 0.062 CID_36332 | CID_36332 | |
| 0.021 | 0.149 | 0.163 | Neuraminidase inhibitor | 0.163 0.005 CID_36332 | CID_36332 | |
| 0.012 | 0.145 | 0.038 | Melatonin agonist | 0.038 0.017 CID_36332 | CID_36332 | |
| 0.068 | 0.211 | 0.147 | Histone deacetylase SIRT1 inhibitor | 0.147 0.064 CID_36332 | CID_36332 | |
| 0.013 | 0.161 | 0.035 | Melatonin 1 agonist | 0.035 0.021 CID_36332 | CID_36332 | |
| 0.103 | 0.265 | 0.203 | Death-associated protein kinase 2 inhibitor | 0.203 0.033 CID_36332 | CID_36332 | |
| 0.07 | 0.251 | 0.128 | Aurora-C kinase inhibitor | 0.128 0.089 CID_36332 | CID_36332 | |
| 0.005 | 0.188 | 0.021 | Melatonin 1 antagonist | 0.021 0.011 CID_36332 | CID_36332 | |
| 0.006 | 0.204 | 0.035 | Melatonin antagonist | 0.035 0.013 CID_36332 | CID_36332 | |
| 0.137 | 0.358 | 0.2 | Ca(v)3.3 blocker | 0.2 0.192 CID_36332 | CID_36332 | |
| 0.052 | 0.321 | 0.139 | CDK3/cyclin E inhibitor | 0.139 0.035 CID_36332 | CID_36332 | |
| 0.008 | 0.291 | 0.017 | Potassium channel (Inward rectifier) 11 blocker | 0.017 0.015 CID_36332 | CID_36332 | |
| 0.059 | 0.647 | 0.137 | Cyclin-dependent kinase 3 inhibitor | 0.137 0.131 CID_36332 | CID_36332 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |